Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

C Katlama, SG Deeks, B Autran, J Martinez-Picado… - The Lancet, 2013 - thelancet.com
Antiretroviral therapy for HIV infection needs lifelong access and strict adherence to
regimens that are both expensive and associated with toxic effects. A curative intervention …

HIV drug development: the next 25 years

C Flexner - Nature reviews Drug discovery, 2007 - nature.com
The development of drugs for HIV infection began soon after the virus was discovered 25
years ago. Since then, progress has been substantial, but numerous uncertainties persist …

[HTML][HTML] Interleukin-2 therapy in patients with HIV infection

INSIGHT–ESPRIT Study Group and … - … England Journal of …, 2009 - Mass Medical Soc
Background Used in combination with antiretroviral therapy, subcutaneous recombinant
interleukin-2 raises CD4+ cell counts more than does antiretroviral therapy alone. The …

Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment

J Rappaport, DJ Volsky - Journal of neurovirology, 2015 - Springer
Combination antiretroviral therapy (ART) has altered the outcomes of HIV infection in treated
populations by greatly reducing the incidence of opportunistic infections, cancer, and HIV …

Functions of γC cytokines in immune homeostasis: current and potential clinical applications

WW Overwijk, KS Schluns - Clinical immunology, 2009 - Elsevier
Cytokines that signal through receptor complexes containing the common γ (γC) chain
receptor subunit are central regulators of lymphocyte homeostasis. In this review, we discuss …

Immunomodulator therapy: monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins

SJ Lee, J Chinen, A Kavanaugh - Journal of Allergy and Clinical …, 2010 - Elsevier
The immune system consists of a diverse array of immunocompetent cells and inflammatory
mediators that exist in complex networks. These components interact through cascades and …

IL-2, IL-7 and IL-15 as immuno-modulators during SIV/HIV vaccination and treatment

A Leone, LJ Picker, DL Sodora - Current HIV research, 2009 - ingentaconnect.com
While highly active antiretroviral therapy (HAART) regimens have proven to be effective in
controlling active HIV replication, complete recovery of CD4+ T cells does not always occur …

Disruption of the γc cytokine network in T cells during HIV infection

D Sirskyj, J Thèze, A Kumar, M Kryworuchko - Cytokine, 2008 - Elsevier
The common gamma chain (γc)-sharing cytokines (IL's-2, 4, 7, 9, 15, and 21) play a vital role
in the survival, proliferation, differentiation and function of T lymphocytes. As such, disruption …

Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on …

A Leone, M Rohankhedkar, A Okoye… - The Journal of …, 2010 - journals.aai.org
CD4+ T cell depletion is a fundamental component of HIV infection and AIDS pathogenesis
and is not always reversed following antiretroviral therapy (ART). In this study, the SIV …

Role of interleukin-2 in patients with HIV infection

SL Pett, AD Kelleher, S Emery - Drugs, 2010 - Springer
Control of viral replication to below the level of quantification using combination antiretroviral
therapy (ART)[cART] has led to a dramatic fall in mortality and morbidity from AIDS …